GO
Loading...
 

The Flaws in Emerging Market Strategy

Tue 02 Apr 13 | 11:35 AM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

The Flaws in Emerging Market Strategy

Tue 02 Apr 13 | 11:35 AM ET
Andrew Weiss, head of pharma and biotech research at Vontobel, tells CNBC why Novartis' failure to win its battle for patent protection for the drug Glivec highlights the flaws in pharma companies' emerging market strategy.
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Wall Street giving this quarter 'a pass': Pro
Thu 17 Apr 14 | 05:00 AM ET
Latest Videos
Happy 25th birthday CNBC!
Thu 17 Apr 14 | 05:00 AM ET
Latest Videos
US main driver for Sodexo: CEO
Thu 17 Apr 14 | 04:30 AM ET
Latest Videos
Dollar: Should you still be long?
Thu 17 Apr 14 | 04:10 AM ET
Go
Displaying results for: Latest Video | US